Tisdag 10 Mars | 14:41:01 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2027-02-25 08:10 Bokslutskommuniké 2026
2026-11-26 08:10 Kvartalsrapport 2026-Q3
2026-08-27 08:10 Kvartalsrapport 2026-Q2
2026-05-29 N/A X-dag ordinarie utdelning NICA 0.00 SEK
2026-05-28 N/A Årsstämma
2026-05-20 08:10 Kvartalsrapport 2026-Q1
2026-03-04 - Extra Bolagsstämma 2026
2026-02-26 - Bokslutskommuniké 2025
2025-10-23 - Kvartalsrapport 2025-Q3
2025-07-10 - Kvartalsrapport 2025-Q2
2025-05-23 - X-dag ordinarie utdelning NICA 0.00 SEK
2025-05-22 - Årsstämma
2025-04-16 - Kvartalsrapport 2025-Q1
2025-02-14 - Bokslutskommuniké 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-09-23 - Extra Bolagsstämma 2024
2024-07-05 - Kvartalsrapport 2024-Q2
2024-05-17 - X-dag ordinarie utdelning NICA 0.00 SEK
2024-05-16 - Årsstämma
2024-04-26 - Kvartalsrapport 2024-Q1
2024-02-09 - Bokslutskommuniké 2023
2023-10-27 - Kvartalsrapport 2023-Q3
2023-07-07 - Kvartalsrapport 2023-Q2
2023-05-05 - X-dag ordinarie utdelning NICA 0.00 SEK
2023-05-04 - Årsstämma
2023-04-28 - Kvartalsrapport 2023-Q1
2023-02-10 - Bokslutskommuniké 2022
2022-11-11 - Kvartalsrapport 2022-Q3
2022-09-15 - Extra Bolagsstämma 2022
2022-08-19 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning NICA 0.00 SEK
2022-06-02 - Årsstämma
2022-04-29 - Kvartalsrapport 2022-Q1
2022-02-08 - Bokslutskommuniké 2021
2021-10-29 - Kvartalsrapport 2021-Q3
2021-08-27 - Kvartalsrapport 2021-Q2
2021-05-28 - X-dag ordinarie utdelning NICA 0.00 SEK
2021-05-27 - Årsstämma
2021-05-07 - Kvartalsrapport 2021-Q1
2021-02-26 - Bokslutskommuniké 2020
2020-10-30 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-29 - X-dag ordinarie utdelning NICA 0.00 SEK
2020-05-28 - Årsstämma
2020-02-26 - Extra Bolagsstämma 2020
2020-02-24 - Kvartalsrapport 2020-Q1
2020-02-07 - Bokslutskommuniké 2019
2019-10-25 - Kvartalsrapport 2019-Q3
2019-08-27 - Kvartalsrapport 2019-Q2
2019-05-31 - X-dag ordinarie utdelning NICA 0.00 SEK
2019-05-29 - Årsstämma
2019-05-10 - Kvartalsrapport 2019-Q1
2019-02-15 - Bokslutskommuniké 2018
2018-11-23 - Kvartalsrapport 2018-Q3
2018-08-23 - Kvartalsrapport 2018-Q2
2018-06-01 - X-dag ordinarie utdelning NICA 0.00 SEK
2018-05-31 - Årsstämma
2018-04-25 - Kvartalsrapport 2018-Q1
2018-02-23 - Bokslutskommuniké 2017
2017-11-23 - Kvartalsrapport 2017-Q3
2017-08-25 - Kvartalsrapport 2017-Q2
2017-06-02 - X-dag ordinarie utdelning NICA 0.00 SEK
2017-06-01 - Årsstämma
2017-05-19 - Kvartalsrapport 2017-Q1
2017-02-23 - Bokslutskommuniké 2016
2016-11-17 - Kvartalsrapport 2016-Q3
2016-09-12 - Extra Bolagsstämma 2016
2016-08-26 - Kvartalsrapport 2016-Q2
2016-06-01 - X-dag ordinarie utdelning NICA 0.00 SEK
2016-05-31 - Årsstämma
2016-05-20 - Kvartalsrapport 2016-Q1
2016-02-19 - Bokslutskommuniké 2015
2015-11-26 - Kvartalsrapport 2015-Q3

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriBioteknik
Nanologica är ett bolag inom life science tools som utvecklar, tillverkar och säljer avancerade insatsvaror till läkemedelsproducerande företag. Nanologicas silikabaserade produkter är speciellt framtagna för rening av peptidläkemedel, såsom insulin och GLP-1-analoger. Nanologica verkar på en global nischmarknad för läkemedel för behandling av diabetes och obesitas. Nanologica grundades 2004 och har sitt huvudkontor i Södertälje.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-03-04 10:56:00

Nanologica AB (publ) ("Nanologica" or the "Company") held an extraordinary general meeting today at which the following resolutions were passed.

For more detailed information on the content of the resolutions, please refer to the complete notice of the extraordinary general meeting, which is available on the Company's website, www.nanologica.com.

Adoption of new articles of association
The general meeting resolved to amend the articles of association, whereby the limits of the articles of association for share capital (item § 4) and number of shares (item § 5) are amended (other parts shall apply unchanged). The share capital shall amount to a minimum of SEK 14,025,000 and a maximum of SEK 56,100,000. The number of shares shall be not less than 275,000,000 and not more than 1,100,000,000.

Resolution on approval of the board of directors' resolution on a new issue of shares with deviation from the shareholders' preferential rights (set-off issue)
The general meeting resolved, in accordance with the proposal put forward by the board of directors under item 7 on the agenda, to approve the board of directors' resolution of January 30, 2026 on a new issue of shares with deviation from the shareholders' preferential rights (set-off issue).
The right to subscribe for new shares shall, with deviation from the shareholders' preferential rights, be granted to Ardena Sweden AB. The reason for the deviation from the shareholders' preferential rights is to fulfill the Company's obligations under the share purchase agreement that the Company has entered into with Ardena regarding the acquisition of all shares in Ardena Södertälje AB. According to the terms and conditions of the share purchase agreement, the purchase price shall be paid by a promissory note which is offset against newly issued shares in the Company.

The set-off issue comprises a new issue of not more than 21,453,780 shares, corresponding to an increase of the Company's share capital by a maximum of SEK 1,094,143. Each share is issued at a price of SEK 0.40 per new share. The subscription price corresponds to the price at which shares are issued in accordance with the board of directors' resolution of January 30, 2026 on a rights issue of shares.

Resolution on approval of the board of directors' resolution on a new issue of shares with deviation from the shareholders' preferential rights (directed issue)
The general meeting resolved, in accordance with the proposal put forward by the board of directors under item 8 on the agenda, to approve the board of directors' resolution of January 30, 2026 on a new issue of shares with deviation from the shareholders' preferential rights (directed issue).
The right to subscribe for new shares shall, with deviation from the shareholders' preferential rights, be granted to a limited group of pre-announced investors. The purpose of the directed share issue and the reason for the deviation from the shareholders' preferential rights is that the board of directors deems it necessary to carry out financing in a time and cost-effective manner in order to quickly meet the Company's liquidity needs through a combination of a smaller directed issue and a rights issue carried out on the same terms. By combining the directed share issue with a rights issue, existing shareholders are given the opportunity to defend their ownership and subscribe for shares on the same terms as the external investors participating in the directed share issue. The Company's CEO Andreas Bhagwani participates in the directed share issue through his wholly-owned company Vega Bianca AB with an amount corresponding to his pro-rata share in the rights issue, on the same terms as other shareholders, which enables the Company to receive the issue proceeds before the rights issue has been completed. In addition, the board of directors believes that it is strategically valuable for the Company to broaden the ownership group with an external investor through the directed share issue.

The directed share issue comprises a new issue of not more than 12,750,000 shares, corresponding to an increase of the Company's share capital by a maximum of SEK 650,250. Each share is issued at a price of SEK 0.40 per new share. The subscription price corresponds to the price at which shares are issued in accordance with the board of directors' resolution of January 30, 2026 on a rights issue of shares.

Resolution on approval of the board of directors' resolution on a new issue of shares with preferential rights for existing shareholders
The general meeting resolved, in accordance with the proposal put forward by the board of directors under item 9 on the agenda, to approve the board of directors' resolution of January 30, 2026 on a new issue of shares with preferential rights for existing shareholders.
The rights issue comprises a new issue of not more than 206,196,246 shares, corresponding to an increase of the Company's share capital by a maximum of SEK 10,516,008.55. Each share is issued at a price of SEK 0.40 per new share. The right to subscribe for new shares shall be granted with preferential rights to those who are registered as shareholders in the Company on the record date for the rights issue. One (1) existing share on the record date of March 9, 2026 entitles to one (1) subscription right. Three (3) subscription rights entitle to subscribe for seven (7) new shares. In addition, investors are offered the opportunity to apply for subscription of shares without subscription rights. The subscription period is expected to run from March 11, 2026 up to and including March 25, 2026.

Resolution on authorization for the board of directors to resolve on new issues of shares to guarantors
The general meeting further resolved to authorize the board of directors to, for the period until the end of the next annual general meeting, on one or more occasions, with deviation from the shareholders' preferential rights and with or without conditions of set-off or other conditions, resolve on the issue of shares to the guarantors of the rights issue.
Upon exercise of the authorization, the terms and conditions for shares shall be the same as in the rights issue. The purpose of the authorization and the reason for the deviation from the shareholders' preferential rights is to be able to carry out an issue of shares as guarantee compensation to the guarantors. The number of shares that may be issued pursuant to the authorization may in total amount to a maximum of the total number of shares corresponding to the agreed guarantee fee that the Company is required to pay to the guarantors.

Resolution on the number of board members, election of a new board member, and resolution on fees
The general meeting resolved to increase the number of board members from five (5) to six (6), and to elect Jeremie Trochu as a new member of the board of directors for the period until the end of the next annual general meeting. It was further resolved that Jeremie Trochu shall receive remuneration in accordance with the remuneration for other members, adjusted with regard to the time of his appointment during the financial year.